Department of Vascular Interventional Surgery, The First Affiliated Hospital of Harbin Medical University, No.23 Youzheng Str, Nangang District, Harbin, 150001, China.
Department of Vascular Interventional Surgery, The First Affiliated Hospital of Harbin Medical University, No.23 Youzheng Str, Nangang District, Harbin, 150001, China.
Atherosclerosis. 2020 Mar;297:47-54. doi: 10.1016/j.atherosclerosis.2020.01.014. Epub 2020 Feb 1.
BACKGROUND AND AIMS: Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease when aortic rupture occurs, especially for elders. There is an urgent need to understand the mechanisms of AAA formation and development at molecular level. Our previous study showed that disintegrin and metalloprotease 10 (ADAM10) played an important role in abdominal aortic aneurysm formation. In this study, we investigated the effects of another ADAM protein (ADMA9) in AAA formation. METHOD AND RESULTS: Using AngII treated human aortic smooth muscle cells (HASMCs) and human aortic endothelial cells (hAoECs) as in vitro AAA model and murine AAA model, ADAM9 was overexpressed suggesting that ADAM9 may play important roles in AAA formation. Further investigation showed that ADAM9 induced inflammation leading to increased macrophage infiltration. ADAM9 was also found to induce cell apoptosis. AKT/NF-κB pathway was activated in murine AAA. Bioinformatic analysis showed that the 3' UTR of ADMA9 was a potential target of miR-126. We investigated the potential of using miR-126 to modulate ADAM9 expression. The expression level of miR-126 was decreased and inversely correlated with the expression of ADAM9 in the in vitro AAA model. Further investigation showed that miR-126 negatively regulated gene expression of ADAM9 and suppressed the production of inflammatory cytokines. miR-126 was also found to improve cell survival and significantly reduce AAA formation in murine AAA. CONCLUSIONS: Our data revealed a link between ADAM9 and AAA formation, providing an approach to control AAA development using miR-126, possibly through modulation of the expression level of ADAM9.
背景与目的:当主动脉破裂发生时,腹主动脉瘤(AAA)是一种危及生命的血管疾病,尤其是老年人。因此,迫切需要从分子水平上了解 AAA 形成和发展的机制。我们之前的研究表明,解整合素金属蛋白酶 10(ADAM10)在腹主动脉瘤形成中发挥重要作用。在这项研究中,我们研究了另一种 ADAM 蛋白(ADMA9)在 AAA 形成中的作用。 方法和结果:使用 AngII 处理的人主动脉平滑肌细胞(HASMCs)和人主动脉内皮细胞(hAoECs)作为体外 AAA 模型和小鼠 AAA 模型,过表达 ADAM9 表明 ADAM9 可能在 AAA 形成中发挥重要作用。进一步的研究表明,ADAM9 诱导炎症导致巨噬细胞浸润增加。还发现 ADAM9 诱导细胞凋亡。AKT/NF-κB 通路在小鼠 AAA 中被激活。生物信息学分析表明,ADMA9 的 3'UTR 是 miR-126 的潜在靶标。我们研究了使用 miR-126 来调节 ADAM9 表达的潜力。miR-126 的表达水平降低,与体外 AAA 模型中 ADAM9 的表达呈负相关。进一步的研究表明,miR-126 负调控 ADAM9 的基因表达,并抑制炎症细胞因子的产生。还发现 miR-126 可改善细胞存活并显著减少小鼠 AAA 的形成。 结论:我们的数据揭示了 ADAM9 与 AAA 形成之间的联系,为使用 miR-126 控制 AAA 发展提供了一种方法,可能通过调节 ADAM9 的表达水平。
Atherosclerosis. 2020-3
Arterioscler Thromb Vasc Biol. 2017-11
Arterioscler Thromb Vasc Biol. 2017-2
Arterioscler Thromb Vasc Biol. 2021-1
Arterioscler Thromb Vasc Biol. 2017-11
Front Pharmacol. 2025-7-23
ACS Appl Mater Interfaces. 2025-6-18
J Diabetes Res. 2025-4-28
Skin Res Technol. 2024-7
Front Cardiovasc Med. 2024-6-4
Curr Atheroscler Rep. 2024-7